Researchers developed MAGIC, an AI-based system integrating automated microscopy and genomics to study chromosomal abnormalities linked to cancer.
Key Details
- 1MAGIC uses automated microscopy, AI-driven image analysis, and single-cell genome sequencing to identify and tag abnormal cells.
- 2The system can analyse nearly 100,000 cells in less than a day, vastly exceeding manual methods.
- 3Chromosomal abnormalities were seen in just over 10% of cell divisions, doubling with mutated p53 gene.
- 4MAGIC relies on a laser and photoconvertible dye to mark target cells, facilitating further analysis.
- 5The tool is versatile and can be trained to identify a variety of visually distinct cellular features.
Why It Matters
MAGIC represents a significant step forward in combining imaging AI and genomic methods for the high-throughput study of cellular abnormalities, offering potential advances in cancer detection and understanding cancer origins. Such AI-driven image analysis tools could pave the way for faster, more precise research and diagnostics in radiology and oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Solid Tumor Drug Development and Personalized Oncology
AI is expediting the timeline and personalization of solid tumor drug development using multi-omics, imaging, and advanced computational models.
•EurekAlert
AI Showcased as Transformative Force at 2025 NFCR Global Summit
The 2025 NFCR Global Summit spotlighted AI's expanding impact from cancer research to patient care, with experts highlighting breakthroughs in imaging, pathology, and multi-modal analytics.
•EurekAlert
Biodegradable Wearable Sensor with AI Enables Interference-Free Respiration Monitoring
Researchers developed a biodegradable, interference-resistant smart mask sensor with AI-driven respiratory classification capability.